CytomX Therapeutics, Inc. — TTAB Proceedings
CytomX Therapeutics, Inc. is a party to 2 TTAB proceedings.
Proceedings
- Proceeding 88237412 — Extensions of Time to Oppose, Terminated (filed 2022-07-27) against NOVARTIS CORPORATION as defendant
- Proceeding 88296649 — Extensions of Time to Oppose, Terminated (filed 2022-08-04) against Iovance Biotherapeutics, Inc. as defendant
Marks in These TTAB Matters
Recent Live Filings
- PROBODY — Pending, filed 2023-11-30
- Trademark 87978555 — Registered, filed 2017-06-20
- CYTOMX — Registered, filed 2017-04-21
- PROBODY — Registered, filed 2015-07-31
Common TTAB Counterparties
- Iovance Biotherapeutics, Inc. — 1 proceedings
- NOVARTIS CORPORATION — 1 proceedings
Recent TTAB Timeline
- 2022-10-25: 88296649 — TERMINATED involving Iovance Biotherapeutics, Inc.
- 2022-10-25: 88296649 — ABANDONMENT NOTED; EXT TERMINATED involving Iovance Biotherapeutics, Inc.
- 2022-08-04: 88237412 — EXTENSION OF TIME GRANTED involving NOVARTIS CORPORATION
- 2022-08-04: 88237412 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving NOVARTIS CORPORATION
- 2022-08-04: 88296649 — EXTENSION OF TIME GRANTED involving Iovance Biotherapeutics, Inc.
- 2022-08-04: 88296649 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Iovance Biotherapeutics, Inc.
- 2022-07-27: 88237412 — EXTENSION OF TIME GRANTED involving NOVARTIS CORPORATION
- 2022-07-27: 88237412 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving NOVARTIS CORPORATION